Hospital
NYU Langone Hospitals
NYU Langone Hospitals was paid $32.22M by Medicaid between Jan 2018 and Dec 2024, across 182 billing codes. Its largest line is 97530, Therapeutic activities, direct patient contact, each 15 minutes — 13% of everything it billed.
33Billing provider infoNYU LANGONE HOSPITALS
NEW YORK, NY 10003
NEW YORK, NY 10003
33aNPI1669578324assigned 09/16/2006
33bProvider typeRehabilitation Hospital Unit
28Total paid$32.22M
24GClaims360,576
24DCodes billed182
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Rehabilitation Hospital Unit providers in New York
Rank by total paid#1 of 7
Median peer was paid$58K
This provider vs. median552×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,817 | $137K | |
| 2019 | 20,676 | $1.68M | |
| 2020 | 53,888 | $4.40M | |
| 2021 | 72,402 | $5.84M | |
| 2022 | 72,870 | $6.18M | |
| 2023 | 74,697 | $7.76M | |
| 2024incomplete | 63,226 | $6.22M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 13% | 31,412 | 11,739 | $4.24M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 13% | 51,341 | 23,674 | $4.19M |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 10% | 2,084 | 2,065 | $3.36M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 9.2% | 18,131 | 15,694 | $2.97M |
| C1889 | Implantable/insertable device, not otherwise classified | 5.6% | 1,861 | 1,840 | $1.82M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4.9% | 14,712 | 13,769 | $1.57M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.0% | 11,066 | 10,431 | $1.30M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.8% | 8,653 | 8,370 | $1.23M |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 3.3% | 8,893 | 2,680 | $1.06M |
| 97161 | 3.1% | 8,781 | 8,630 | $994K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 2.2% | 21,798 | 10,313 | $720K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 2.1% | 10,857 | 6,440 | $687K |
170 more codes
| 99214 | Doctor's office visit, returning patient (more involved) | 1.9% | 4,936 | $615K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1.6% | 3,229 | $525K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.6% | 5,023 | $520K |
| C1776 | Joint device (implantable) | 1.4% | 68 | $436K |
| 20610 | 1.3% | 851 | $407K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 1.2% | 1,749 | $376K |
| 97165 | 1.1% | 3,357 | $370K | |
| 97116 | 1.1% | 4,242 | $339K | |
| 96415 | <1% | 839 | $279K | |
| 72082 | <1% | 5,126 | $272K | |
| 29888 | <1% | 89 | $263K | |
| 29881 | <1% | 195 | $232K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 1,039 | $177K |
| 76000 | <1% | 1,099 | $147K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 977 | $142K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 9,038 | $129K |
| 73562 | <1% | 5,173 | $129K | |
| 73221 | <1% | 589 | $120K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 615 | $103K |
| 73564 | <1% | 3,768 | $101K | |
| 97162 | <1% | 805 | $97K | |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | <1% | 57 | $91K |
| 77073 | <1% | 4,033 | $90K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,852 | $88K |
| 20611 | <1% | 118 | $85K | |
| 92609 | <1% | 792 | $83K | |
| 97113 | <1% | 602 | $79K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,070 | $75K |
| 73030 | <1% | 2,591 | $73K | |
| 73502 | <1% | 2,641 | $72K | |
| 73610 | <1% | 2,767 | $70K | |
| 72141 | <1% | 331 | $70K | |
| 29827 | <1% | 25 | $66K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 654 | $64K |
| 73630 | <1% | 3,115 | $61K | |
| 73130 | <1% | 2,493 | $50K | |
| 76882 | <1% | 1,002 | $49K | |
| 92523 | <1% | 247 | $48K | |
| 73110 | <1% | 1,986 | $44K | |
| 73560 | <1% | 2,025 | $43K | |
| 95911 | <1% | 235 | $39K | |
| 99205 | Prolong outpt/office vis | <1% | 294 | $39K |
| 29705 | <1% | 133 | $37K | |
| 73080 | <1% | 1,620 | $36K | |
| 95886 | <1% | 771 | $36K | |
| 72170 | <1% | 2,150 | $34K | |
| 72110 | <1% | 1,185 | $33K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,092 | $33K |
| 97166 | <1% | 270 | $32K | |
| 96116 | <1% | 195 | $32K | |
| 72100 | <1% | 1,151 | $31K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 5,159 | $31K |
| 80053 | Comprehensive metabolic panel | <1% | 1,779 | $29K |
| 97542 | <1% | 229 | $28K | |
| J3490 | Unclassified drugs | <1% | 7,240 | $28K |
| 73590 | <1% | 1,285 | $27K | |
| S2900 | Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) | <1% | 14 | $24K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 754 | $22K |
| 29823 | <1% | 28 | $21K | |
| J2704 | Injection, propofol, 10 mg | <1% | 5,722 | $19K |
| 72083 | <1% | 280 | $18K | |
| 86900 | <1% | 660 | $17K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 191 | $17K |
| C1769 | Guide wire | <1% | 123 | $17K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 40 | $15K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 666 | $12K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 114 | $12K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 4,679 | $12K |
| 73090 | <1% | 772 | $12K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 1,998 | $11K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 3,862 | $11K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 892 | $11K |
| 76881 | <1% | 201 | $10K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 357 | $10K |
| 20550 | <1% | 13 | $9K | |
| 64642 | <1% | 12 | $9K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,113 | $9K |
| 72050 | <1% | 250 | $8K | |
| 86850 | <1% | 663 | $8K | |
| 72040 | <1% | 261 | $8K | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 607 | $8K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 40 | $8K |
| 96132 | <1% | 67 | $7K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 599 | $6K |
| 86901 | <1% | 662 | $5K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 991 | $5K |
| 76942 | <1% | 27 | $5K | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 1,891 | $5K |
| 73140 | <1% | 279 | $5K | |
| 87070 | <1% | 952 | $5K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 4,869 | $5K |
| 36415 | Collection of venous blood by venipuncture | <1% | 610 | $5K |
| 80076 | <1% | 294 | $5K | |
| 86160 | <1% | 329 | $4K | |
| 96136 | <1% | 65 | $4K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,837 | $4K |
| 96137 | <1% | 53 | $4K | |
| 86140 | <1% | 1,684 | $4K | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 142 | $3K |
| 73700 | <1% | 43 | $3K | |
| L3808 | Wrist hand finger orthosis, rigid without joints, may include soft interface material; straps, custom fabricated, includes fitting and adjustment | <1% | 14 | $3K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 254 | $3K |
| 73552 | <1% | 143 | $3K | |
| Q3014 | Telehealth originating site facility fee | <1% | 103 | $3K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,919 | $3K |
| 85652 | <1% | 1,996 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,887 | $2K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 4,289 | $2K |
| 84703 | <1% | 1,883 | $2K | |
| 94060 | <1% | 18 | $2K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 522 | $2K |
| 94726 | <1% | 48 | $2K | |
| 94729 | <1% | 48 | $2K | |
| 72114 | <1% | 38 | $2K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 164 | $2K |
| 73523 | <1% | 57 | $2K | |
| 80061 | Lipid panel | <1% | 95 | $2K |
| 86225 | <1% | 275 | $2K | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 1,057 | $1K |
| G0008 | Administration of influenza virus vaccine | <1% | 82 | $1K |
| 90686 | <1% | 65 | $1K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 496 | $1K |
| 96121 | <1% | 26 | $1K | |
| 73521 | <1% | 35 | $1K | |
| 99283 | Emergency room visit (moderate) | <1% | 14 | $1K |
| 72081 | <1% | 43 | $995.54 | |
| 87640 | <1% | 46 | $898.22 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 14 | $863.39 |
| 85027 | <1% | 331 | $847.26 | |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 129 | $701.76 |
| 81003 | <1% | 525 | $692.18 | |
| 72070 | <1% | 25 | $687.99 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 67 | $668.55 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 109 | $616.79 |
| 85730 | <1% | 155 | $616.62 | |
| 73100 | <1% | 42 | $613.10 | |
| 77080 | <1% | 13 | $558.86 | |
| 85610 | <1% | 162 | $519.80 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 153 | $507.37 |
| 72202 | <1% | 15 | $414.99 | |
| 73000 | <1% | 13 | $403.03 | |
| 73070 | <1% | 17 | $373.10 | |
| 77072 | <1% | 12 | $352.06 | |
| 86431 | <1% | 88 | $283.59 | |
| 97810 | <1% | 32 | $282.69 | |
| 73010 | <1% | 13 | $271.36 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 48 | $252.87 |
| 97811 | <1% | 32 | $240.57 | |
| 99284 | Emergency room visit (serious) | <1% | 14 | $205.31 |
| 84156 | <1% | 96 | $201.65 | |
| 86200 | <1% | 30 | $195.44 | |
| 87081 | <1% | 46 | $181.24 | |
| 71045 | Radiologic examination, chest; single view | <1% | 14 | $174.83 |
| 82948 | <1% | 159 | $78.68 | |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | <1% | 12 | $75.60 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 51 | $66.34 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | <1% | 40 | $63.13 |
| 86039 | <1% | 15 | $60.92 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 55 | $54.41 |
| S0028 | Injection, famotidine, 20 mg | <1% | 57 | $43.61 |
| 81015 | <1% | 28 | $31.96 | |
| 84550 | <1% | 15 | $22.60 | |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | <1% | 405 | $9.88 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | <1% | 53 | $2.44 |
| G8987 | Self care functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 25 | $0.20 |
| G8988 | Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | <1% | 25 | $0.20 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 257 | $0.20 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | <1% | 252 | $0.20 |
| G8984 | Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 12 | $0.00 |
| G8985 | Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSMITH, WESLEY (VP REVENUE CYCLE)
Parent organizationNYU LANGONE HOSPITALS
| Provider | Location | Paid |
|---|---|---|
| NYU Langone Hospitals | Brooklyn, NY | $303.18M |
| NYU Langone Hospitals | New York, NY | $238.69M |
| NYU Langone Hospitals | New York, NY | $117.59M |
| NYU Langone Hospitals | Mineola, NY | $69.77M |
| NYU Langone Hospitals | New York, NY | $3.50M |
| NYU Langone Hospitals | Brooklyn, NY | $453K |
| NYU Langone Hospitals | Brooklyn, NY | $99K |
| NYU Langone Hospitals | Brooklyn, NY | $9K |
| NYU Hospitals Center | New York, NY | $55.44 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.